Grant: Discovery Grants Program - Individual
University of Toronto
$214,000.00
Solution NMR studies of the Hsp104/ClpB Chaperone
EF 2022-23
Résumé
Several human diseases are caused by protein misfolding and the accumulation of toxic protein aggregates. These include Alzheimer's and Parkinson's diseases, type II diabetes and the spongiform encephalopathies such as Creutzfeldt-Jakob disease. In order to develop effective therapeutic strategies to prevent, slow-down or reverse the progression of these diseases, an understanding of the molecular mechanisms involved in triggering and/or reversing protein aggregation inside the cell must be achieved. This, in turn, is predicated on a detailed, quantitative characterization of the structural and motional properties of the molecular players that are involved in the aggregation reversal process. One such set of players is the Hsp100/ClpB chaperones. These can be thought of as miniature molecular machines that are composed of moving parts. Understanding how these machines function requires a detailed study of their three-dimensional structures and how these structures change over time, as the machines carry out their tasks in the cell. The goal of the present proposal is, therefore, to use solution Nuclear Magnetic Resonance (NMR) Spectroscopy (i) to map out the important motions within the Hsp100/ClpB machine, (ii) to establish at atomic level resolution the sites of interaction between chaperone and target substrates, (iii) to determine how the different moving parts of the Hsp100/ClpB molecular machine are organized relative to each other and how their relative positions change in response both to substrate binding and to the presence of different nucleotides such as ATP and ADP and (iv) to characterize interactions between ClpB and other molecular players involved in the disaggregation process. The proposed research will provide detailed insight into the mechanisms by which large molecular machines are able to disaggregate proteins, ultimately contributing to the prevention of neurodegenerative disease. During the course of the proposed study, new NMR methods will be developed that will have a broad impact on a range of macromolecular applications, including those that involve molecular interactions that are often weak and hence recalcitrant to detailed studies by other biophysical approaches.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
RGPIN-2015-04347
Name nom
Kay, Lewis
Department département
Molecular Genetics - Molecular Genetics
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2022
Competition year année de concours
2015
Award amount
214000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5400
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Biochemistry
Research subject fr
Biochimie
Installment
inst:8;9
Partie
2
Nb partie
9
Application title
Solution NMR studies of the Hsp104/ClpB Chaperone
Application summary
Several human diseases are caused by protein misfolding and the accumulation of toxic protein aggregates. These include Alzheimer's and Parkinson's diseases, type II diabetes and the spongiform encephalopathies such as Creutzfeldt-Jakob disease. In order to develop effective therapeutic strategies to prevent, slow-down or reverse the progression of these diseases, an understanding of the molecular mechanisms involved in triggering and/or reversing protein aggregation inside the cell must be achieved. This, in turn, is predicated on a detailed, quantitative characterization of the structural and motional properties of the molecular players that are involved in the aggregation reversal process. One such set of players is the Hsp100/ClpB chaperones. These can be thought of as miniature molecular machines that are composed of moving parts. Understanding how these machines function requires a detailed study of their three-dimensional structures and how these structures change over time, as the machines carry out their tasks in the cell. The goal of the present proposal is, therefore, to use solution Nuclear Magnetic Resonance (NMR) Spectroscopy (i) to map out the important motions within the Hsp100/ClpB machine, (ii) to establish at atomic level resolution the sites of interaction between chaperone and target substrates, (iii) to determine how the different moving parts of the Hsp100/ClpB molecular machine are organized relative to each other and how their relative positions change in response both to substrate binding and to the presence of different nucleotides such as ATP and ADP and (iv) to characterize interactions between ClpB and other molecular players involved in the disaggregation process. The proposed research will provide detailed insight into the mechanisms by which large molecular machines are able to disaggregate proteins, ultimately contributing to the prevention of neurodegenerative disease. During the course of the proposed study, new NMR methods will be developed that will have a broad impact on a range of macromolecular applications, including those that involve molecular interactions that are often weak and hence recalcitrant to detailed studies by other biophysical approaches.